Results 71 to 80 of about 9,555 (129)

Frequency and Structure of Drug Resistance of M. tuberculosis in Pulmonary and Extrapulmonary Tuberculosis

open access: yesТуберкулез и болезни лёгких
The objective: to assess changes in the data on drug resistance of M. tuberculosis for 2015-2021 and compare it with data for 2012-2014.Subjects and Methods.
P. K. Yablonskiy   +3 more
doaj   +1 more source

Antimicrobial Susceptibility Patterns and Proportion of Multidrug‐Resistant Uropathogens in a Remote Tertiary Hospital in Bhutan: A Cross‐Sectional Study

open access: yesHealth Science Reports, Volume 9, Issue 10, October 2026.
ABSTRACT Background and Aims A surge in antimicrobial resistance and multidrug‐resistant organisms among uropathogens have complicated its management over time. It is imperative to examine epidemiology and local antimicrobial susceptibility patterns to promote evidence‐based management.
Sanga Tenzin   +7 more
wiley   +1 more source

Comparison of clinical characteristics (non-categorical values) of MDR, p-XDR and XDR-TB isolates.

open access: yes, 2013
P values were calculated using Kruskal-Wallis test ...
Rupak Singla (265018)   +9 more
core   +1 more source

Yield of Systematic Longitudinal Screening of Household Contacts of Pre-Extensively Drug Resistant (PreXDR) and Extensively Drug Resistant (XDR) Tuberculosis Patients in Mumbai, India

open access: yesTropical Medicine and Infectious Disease, 2020
While risk of tuberculosis (TB) is high among household contacts (HHCs) of pre-extensively drug resistant (pre-XDR) TB and XDR-TB, data on yield of systematic longitudinal screening are lacking.
Roma Haresh Paryani   +12 more
doaj   +1 more source

Post‐Tuberculosis Lung Disease: Clinicopathologic Insights, Diagnosis, Prevention, and Management

open access: yesMedComm, Volume 7, Issue 10, October 2026.
A comprehensive review on post‐tuberculosis lung disease (PTLD) addresses the epidemiology, pathogenesis, clinical phenotypes and management, risk factors, prevention and systems approach, and future directions. This review provides standardized definitions, mechanistic insights and biomarkers of PTLD development, and clinical strategies for PTLD ...
Radha Gopalaswamy, Selvakumar Subbian
wiley   +1 more source

MDR-TB and XDR-TB: drug resistance and treatment outcomes

open access: yes, 2009
We read with interest the study by HWANG et al., which continues the discussion on factors associated with poor outcomes in the treatment ofmultidrug-resistant tuberculosis (MDRTB) and extensively drug-resistant tuberculosis (XDR-TB).
Migliori GB   +14 more
core   +1 more source

Comparison of clinical characteristics (categorical values) of MDR, p-XDR and XDR-TB isolates.

open access: yes, 2013
P values were calculated using chi-square test, values
Rupak Singla (265018)   +9 more
core   +1 more source

Stability analysis results of SNPs for common mutations from RR-TB, HR-TB, MDR-TB, and Pre-XDR-TB using Predict SNP.

open access: yes
Stability analysis results of SNPs for common mutations from RR-TB, HR-TB, MDR-TB, and Pre-XDR-TB using Predict SNP.
George Priya Doss C (8653101)   +2 more
core   +1 more source

Treatment outcome of MDR (first-line drug resistance only), pre-XDR and XDR-TB patients.

open access: yes, 2013
Legend: astart of BELTA-TBnet in 2005 bincluding 3 isolates with unknown amikacin susceptibility cincluding 1 isolate with unknown amikacin susceptibility MDR: first-line drug resistance only Pre-XDR: MDR with additional resistance to either a ...
Maryse Fauville-Dufaux (62783)   +7 more
core   +1 more source

Clonal Expansion of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis, Japan

open access: yesEmerging Infectious Diseases, 2010
The emergence and spread of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) has raised public health concern about global control of TB.
Yoshiro Murase   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy